Robeco Institutional Asset Management B.V. grew its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 69.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 75,443 shares of the financial services provider’s stock after buying an additional 30,902 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in MetLife were worth $5,955,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. raised its stake in shares of MetLife by 3.6% during the third quarter. Blue Trust Inc. now owns 3,585 shares of the financial services provider’s stock valued at $295,000 after acquiring an additional 125 shares during the last quarter. Trustmark Bank Trust Department raised its stake in shares of MetLife by 4.6% during the third quarter. Trustmark Bank Trust Department now owns 2,870 shares of the financial services provider’s stock valued at $236,000 after acquiring an additional 127 shares during the last quarter. Daymark Wealth Partners LLC raised its stake in shares of MetLife by 4.2% during the third quarter. Daymark Wealth Partners LLC now owns 3,192 shares of the financial services provider’s stock valued at $263,000 after acquiring an additional 130 shares during the last quarter. Cornerstone Wealth Group LLC raised its stake in shares of MetLife by 4.9% during the third quarter. Cornerstone Wealth Group LLC now owns 2,790 shares of the financial services provider’s stock valued at $230,000 after acquiring an additional 130 shares during the last quarter. Finally, UMB Bank n.a. raised its stake in shares of MetLife by 1.9% during the third quarter. UMB Bank n.a. now owns 7,040 shares of the financial services provider’s stock valued at $580,000 after acquiring an additional 132 shares during the last quarter. 94.99% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several equities analysts have recently commented on MET shares. Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and set a $87.00 price objective on shares of MetLife in a research note on Thursday, March 26th. Wall Street Zen raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Saturday, April 11th. Barclays lowered their price objective on shares of MetLife from $92.00 to $89.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Morgan Stanley decreased their price target on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Finally, Bank of America decreased their price target on shares of MetLife from $103.00 to $99.00 and set a “buy” rating for the company in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and an average target price of $93.38.
MetLife Price Performance
MET stock opened at $77.55 on Thursday. MetLife, Inc. has a 1 year low of $67.33 and a 1 year high of $83.85. The company has a market cap of $50.57 billion, a P/E ratio of 16.50, a PEG ratio of 0.68 and a beta of 0.74. The firm has a 50-day moving average of $73.07 and a 200 day moving average of $76.88. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The company had revenue of $52.44 billion during the quarter, compared to the consensus estimate of $31.43 billion. During the same period in the prior year, the firm earned $2.08 earnings per share. MetLife’s revenue was up 27.6% on a year-over-year basis. On average, sell-side analysts forecast that MetLife, Inc. will post 9.65 EPS for the current year.
Key MetLife News
Here are the key news stories impacting MetLife this week:
- Positive Sentiment: MetLife told shareholders to reject a mini?tender offer from Potemkin Limited — the company framed the unsolicited $44.20 bid as opportunistic and well below market, signaling active management protection of shareholder value. MetLife Recommends Shareholders Reject “Mini?Tender” Offer by Potemkin Limited
- Positive Sentiment: Concert bookings at MetLife Stadium (e.g., Usher & Chris Brown two?night event) keep venue utilization and non?insurance revenue opportunities visible to investors. Usher and Chris Brown bring the ‘R&B Tour’ to MetLife for two?night event
- Positive Sentiment: MetLife Foundation awarded over $6.5M globally, reinforcing ESG/PR initiatives that can support brand and stakeholder relations. MetLife Foundation Awards Over $6.5 Million Globally to Address Essential Community Needs
- Neutral Sentiment: MetLife Stadium is being temporarily rebranded for the 2026 FIFA World Cup (New York?New Jersey Stadium), increasing global visibility but with unclear direct financial impact on MetLife the insurer. MetLife Stadium temporarily changes its name for World Cup
- Negative Sentiment: Broad negative press about planned NJ Transit fare surges to MetLife Stadium for World Cup events (reports of $80–$100+ one?way fares) has drawn political pushback from leaders and could create reputational and logistical headaches for stadium events. That controversy can translate into headline risk for MetLife’s stadium association. Trumpflation hits the World Cup: Fans face $80–$100 transit fares on top of $4,000?plus tickets
- Negative Sentiment: Political leaders including Chuck Schumer and Kathy Hochul publicly criticized high train fares and urged that transport costs be covered, amplifying the negative publicity tied to World Cup logistics at MetLife Stadium. Chuck Schumer, Kathy Hochul Slam FIFA For $100 Train Tickets To MetLife Stadium, Urge Covering Transport For Fans Amid ‘$11 Billion Windfall’
- Negative Sentiment: Bank of America trimmed its price target on MET from $103 to $99 (still a Buy rating), which can exert near?term selling pressure despite the remaining upside the analyst sees. MetLife (NYSE:MET) Price Target Cut to $99.00 by Analysts at Bank of America
About MetLife
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Featured Articles
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
